Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 9, 1999, Pages 968-973

  Purello D'Ambrosio, F ^a,d   Gangemi, S ^a   Isola, S ^a   La Motta, N ^a   Puccinelli, P ^b   Parmiani, S ^b   Savi, E ^c   Ricciardi, L ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b ALK Abello SpA   (Italy)

^c Ospedale Civile di Piacenza   (Italy)

^d Viale Principe Umberto ^*  (Italy)

Author keywords

Clinical efficacy; Parietaria allergy; Placebo controlled study; Sublingual immunotherapy

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PLACEBO; POLLEN EXTRACT;

ADULT; ANTIBODY DETECTION; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; ASTHMA; CONJUNCTIVITIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOTHERAPY; MALE; MIDDLE AGED; PLANT PROTEINS; POLLEN; RHINITIS; SEASONS;

EID: 0032854220     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00203.x     Document Type: Article

References (28)

1. Mailing H-J, Weeke B. Position paper, Immunotherapy. Allergy 1993;48 Suppl 14:9.
2. Weber RW. Immunotherapy with allergens. JAMA 199;278:1881-1887.
3. Wheeler AW, Drachenberg KJ. New routes and formulations for allergen-specific immunotherapy. Allergy 1997;52:602-612.
4. Mailing H-J. Sublingual immunotherapy. Clin Exp Allergy 1996;26:1228-1231.
5. Bousquet J, Lockey RF, Mailing H-J. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53 Suppl 44.
6. Scadding K, Brostoff J, Low dose sublingual therapy in patients with allergic rhinitis due to dust mite. Clin Allergy 1986;16:493-499.
7. van Nickerk CH, De Wet JI. Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay fever: a double blind study. Clin Allergy 1987;17:507-513.
8. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol (Madr) 1990;18:277-284.
9. Novembre E, Marano E, Bernardini R, Caria M, Dini L, Vierucci A. Studio controllato con l'immunoterapia sublinguale nel trattamento dell'asma allergico nel bambino. Riv It Pediatr 1991;17:75-78.
10. Nelson HS, Oppenheimer J, Vatsia CA, Buchmeier A. A double blind placebo controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92:229-236.
11. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-313.
12. Casanovas M, Guerra F, Moreno C, Miguel R, Maranon F, Daza JC. Double blind placebo controlled clinical trial of preseasonal treatment with allergenic extracts of Oleo europaea pollen administered sublingually. J Investig Allergol Clin Immunol 1994;4:305-314.
13. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double blind study, J Investig Allergol Clin Immunol 1995;5:25-30.
14. Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:224-230.
15. Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996;26:1253-1261.
16. Purello D'Ambrosin F, Ricciardi L, Isola S, et al. Rush sublingual immunotherapy in Parietaria-allergic patients. Allergol Immunopathol (Madr) 1996;21:146-151.
17. Mailing H-J, Abrau-Nogueira J, Alvarez-Cuesta E, et al. Position paper. Local immunotherapy. Allergy 1998;53:933-944.
18. Hirsch T, Sahn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite (D. pt.) in children. Pediatr Allergy Immunol 1997;8:21-27.
19. Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-632.
20. D'Amato G, Errigo E, Bonini S. Allergenic pollen and pollinosis in Italy. In: D'Amato G, Spieksma FThM, Bonini S, editors. Allergenic pollen and pollinosis in Europe. Oxford: Blackwell Science, 1991:113-118.
21. Crimi N, Palermo F, Pistorio E, et al. La pollinosi nella Sicilia orientale. G Ital Allergol Immunol Clin 1991;1:575-577.
22. Carreira J, Rubio M, Herrero T, et al. Collaborative clinical assay of the biological potency of allergen skin-test extracts. Clin Allergy 1984;14:503-507.
23. Carreira J, Lombardero M, Ventas P. New developments in in vitro methods. Quantification of clinically relevant allergens in mass units. Stuttgart: Gustav Fischer Verlag, 1994.
24. Corbi AL, Ley V, Sanchez-Madrid F, Carreira J. Isolation of the major IgE binding protein from Porietaria judaica pollen using monoclonal antibodies. Mol Immunol 1985;21:1081-1087.
25. Corbi AL, Ayuso R, Lombardero M, Duffort O, Carreira J. A competitive solid-phase radioimmunoassay for quantitation of the major allergen of Parietaria pollen. J Immunol Methods 1985;83:83-88.
26. Bagnasco M, Mariani M, Passalacqua C, et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings, J Allergy Clin Immunol 1997;100:122-129.
27. Bousquet J, Scheinmann P, Giunnepain MT, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to housedust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249-260.
28. Tari MG, Mancino M, Madonna G, Buzzoni L, Parmiani S. Immunologic evaluation of 24 month course of sublingual immunotherapy. Allergol Immunopathol (Madr) 1994;22:209-216.